Markets › India › NSE › ORCHPHARMA

Orchid Pharma Ltd

NSE:ORCHPHARMAHealthcare

₹893.50−1.95%At closeAt close · Mon 19 Oct · ≈ AED 34.52 · Market cap $574.08M · Next earnings Mon 16 Nov

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	(1.2)	(0.0)	0.5	0.9	1.0	0.2	−79.3%
Depreciation & amortization	1.1	0.9	0.5	0.3	0.3	0.0	−100.0%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	(0.4)	0.6	(0.8)	(0.1)	(1.1)	0.5	+148.0%
Operating cash flow	0.2	0.9	0.2	1.3	0.2	1.1	+471.9%
Capital expenditure	(0.0)	(0.1)	(0.8)	(0.6)	(1.5)	(3.8)	−155.5%
Acquisitions	0.0	1.1	0.0	0.0	0.0	0.1	—
Investing cash flow	0.7	1.1	(0.3)	(3.1)	(0.3)	(3.0)	−998.6%
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	(1.3)	(1.8)	0.6	(2.1)	0.3	1.8	+551.9%
Financing cash flow	(1.6)	(2.2)	0.3	1.7	0.3	1.7	+581.5%
Free cash flow	0.2	0.8	(0.7)	0.6	(1.3)	(2.7)	−109.1%
Net change in cash	(0.7)	(0.1)	0.2	(0.2)	0.2	0.6	+237.0%

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.